Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada.
Dai WF, Beca J, Croxford R, Isaranuwatchai W, Menjak IB, Petrella TM, Mittmann N, Earle CC, Gavura S, Mercer RE, Hanna TP, Chan KKW. Dai WF, et al. Among authors: isaranuwatchai w. Int J Cancer. 2021 Apr 15;148(8):1910-1918. doi: 10.1002/ijc.33357. Epub 2020 Nov 7. Int J Cancer. 2021. PMID: 33105030 Free article.
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand.
Rattanavipapong W, Poonsiri C, Isaranuwatchai W, Iamsirithaworn S, Apakupakul J, Sonthichai C, Kitphati R, Teerawattananon Y. Rattanavipapong W, et al. Among authors: isaranuwatchai w. Appl Health Econ Health Policy. 2023 May;21(3):511-522. doi: 10.1007/s40258-023-00796-7. Epub 2023 Mar 16. Appl Health Econ Health Policy. 2023. PMID: 36928779 Free PMC article. Review.
Economic evaluation of smoking cessation in Ontario's regional cancer programs.
Djalalov S, Masucci L, Isaranuwatchai W, Evans W, Peter A, Truscott R, Cameron E, Mittmann N, Rabeneck L, Chan K, Hoch JS. Djalalov S, et al. Among authors: isaranuwatchai w. Cancer Med. 2018 Sep;7(9):4765-4772. doi: 10.1002/cam4.1495. Epub 2018 Jul 17. Cancer Med. 2018. PMID: 30019421 Free PMC article.
Improved survival in overweight and obese patients with aggressive B-cell lymphoma treated with rituximab-containing chemotherapy for curative intent.
Stevenson JKR, Qiao Y, Chan KKW, Beca J, Isaranuwatchai W, Guo H, Schwartz D, Arias J, Gavura S, Dai WF, Kouroukis CT, Cheung MC. Stevenson JKR, et al. Among authors: isaranuwatchai w. Leuk Lymphoma. 2019 Jun;60(6):1399-1408. doi: 10.1080/10428194.2018.1538509. Epub 2018 Dec 5. Leuk Lymphoma. 2019. PMID: 30516081
Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial.
Hoch JS, Hay A, Isaranuwatchai W, Thavorn K, Leighl NB, Tu D, Trenaman L, Dewa CS, O'Callaghan C, Pater J, Jonker D, Chen BE, Mittmann N. Hoch JS, et al. Among authors: isaranuwatchai w. BMC Cancer. 2019 Jun 7;19(1):552. doi: 10.1186/s12885-019-5779-x. BMC Cancer. 2019. PMID: 31174497 Free PMC article.
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Chan KKW, Guo H, Cheng S, Beca JM, Redmond-Misner R, Isaranuwatchai W, Qiao L, Earle C, Berry SR, Biagi JJ, Welch S, Meyers BM, Mittmann N, Coburn N, Arias J, Schwartz D, Dai WF, Gavura S, McLeod R, Kennedy ED. Chan KKW, et al. Among authors: isaranuwatchai w. Cancer Med. 2020 Jan;9(1):160-169. doi: 10.1002/cam4.2705. Epub 2019 Nov 13. Cancer Med. 2020. PMID: 31724340 Free PMC article.
153 results